Recent advances in feature selection methods for breast cancer recurrence prediction: A systematic review.

A Areeba Ali Kahn (Services Institute of Medical Sciences, Lahore, Pakistan) J Jamila Begum Jabar Ali (Texas Tech University Health Sciences Center, El Paso, El Paso, TX) A Amar Lal (9Penn State Health Milton S Hershey Medical, Hershey, United States) A Anvitha Soundararajan (Tech University Health Sciences Center, El Paso, TX) S Sohaib Rasool (Bakhtawar Amin Medical and Dental College, Multan, Pakistan) R Roshan Afshan (University of Michigan, Ann Arbor, MI) S Sophia Josephine Herrada (University of Texas at Austin, Austin, TX) A Azucena Del-Real (Texas Tech University of Health Sciences Center, El Paso, TX) R Roberto Prieto (El Paso Cancer Treatment Center, El Paso, TX) J Juan Herrada (Texas Tech University Health Sciences Center, El Paso, TX)

Abstract

e13664 Background: Breast cancer recurrence prediction using genomic data faces challenges due to high dimensionality and complex biological relationships. This review evaluates recent methodological advances in feature selection approaches for improving prediction accuracy while preserving biological relevance. Methods: We systematically searched SCOPUS, Web of Science, and PubMed databases and identified studies published from 2018 to 2024 focusing on feature selection methods for breast cancer recurrence prediction. We analyzed four novel feature selection methods that outperform conventional univariate and multivariate approaches. These include Outlier-based Gene Selection (OGS), Semi-Supervised Survival Laplacian Regression (S3LR), pathway-based classification, and an ensemble systems biology approach. These methods were evaluated using standardized genomic datasets to compare their performance in terms of prediction accuracy, dimensionality reduction, computational efficiency, and biological significance. Results: The OGS method achieved the highest subtype-specific accuracy (F1 score: 1.0 for basal subtype) while reducing features by 91%. S3LR demonstrated superior handling of censored data (C-index: 68.80%) with 95% dimensionality reduction. The pathway-based approach maintained 85% accuracy across subtypes with 98% feature reduction. The ensemble method showed balanced performance (F1: 0.94) with 68% feature reduction. All methods demonstrated significant enrichment in cancer-related pathways (p < 0.001). Comparative analysis revealed method-specific strengths: OGS excelled in outlier detection, S3LR in handling censored data, pathway-based in biological interpretation, and ensemble in network analysis. Conclusions: Modern feature selection methods demonstrated better accuracy with fewer features compared to traditional statistical and machine learning approaches. Future studies focusing on the clinical application of these methods for real-time prediction are needed.

Article Details

Volume / Issue Vol. 43, Issue 16_suppl
Published June 01, 2025
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (10)

A

Areeba Ali Kahn

Services Institute of Medical Sciences, Lahore, Pakistan

J

Jamila Begum Jabar Ali

Texas Tech University Health Sciences Center, El Paso, El Paso, TX

A

Amar Lal

9Penn State Health Milton S Hershey Medical, Hershey, United States

A

Anvitha Soundararajan

Tech University Health Sciences Center, El Paso, TX

S

Sohaib Rasool

Bakhtawar Amin Medical and Dental College, Multan, Pakistan

R

Roshan Afshan

University of Michigan, Ann Arbor, MI

S

Sophia Josephine Herrada

University of Texas at Austin, Austin, TX

A

Azucena Del-Real

Texas Tech University of Health Sciences Center, El Paso, TX

R

Roberto Prieto

El Paso Cancer Treatment Center, El Paso, TX

J

Juan Herrada

Texas Tech University Health Sciences Center, El Paso, TX